BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 31969088)

  • 1. Nonalcoholic Fatty Liver Disease versus Alcohol-related Liver Disease: Is it Really so Different?
    Craciun A; Lackner C; Cortez-Pinto H
    Curr Pharm Des; 2020; 26(10):1093-1109. PubMed ID: 31969088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcoholic liver disease presents at advanced stage and progresses faster compared to non-alcoholic fatty liver diseas.
    Shoreibah M; Raff E; Bloomer J; Kakati D; Rasheed K; Kuo YF; Singal AK
    Ann Hepatol; 2016; 15(2):183-9. PubMed ID: 26845595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage.
    Neuman MG; French SW; Zakhari S; Malnick S; Seitz HK; Cohen LB; Salaspuro M; Voinea-Griffin A; Barasch A; Kirpich IA; Thomes PG; Schrum LW; Donohue TM; Kharbanda KK; Cruz M; Opris M
    Exp Mol Pathol; 2017 Feb; 102(1):162-180. PubMed ID: 28077318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver Transplantation for Alcoholic and Nonalcoholic Fatty Liver Disease: Pretransplant Selection and Posttransplant Management.
    Siddiqui MS; Charlton M
    Gastroenterology; 2016 Jun; 150(8):1849-62. PubMed ID: 26971826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease.
    Staufer K; Huber-Schönauer U; Strebinger G; Pimingstorfer P; Suesse S; Scherzer TM; Paulweber B; Ferenci P; Stimpfl T; Yegles M; Datz C; Trauner M
    J Hepatol; 2022 Oct; 77(4):918-930. PubMed ID: 35605744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities.
    Idalsoaga F; Kulkarni AV; Mousa OY; Arrese M; Arab JP
    Front Med (Lausanne); 2020; 7():448. PubMed ID: 32974366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrosis and alcohol-related liver disease.
    Lackner C; Tiniakos D
    J Hepatol; 2019 Feb; 70(2):294-304. PubMed ID: 30658730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of trans fat and alcohol has divergent effects on atherogenic diet-induced liver injury in rodent models of steatohepatitis.
    Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Krag A; Karsdal MA; Nielsen MJ; Brockbank S; Cruwys S
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G410-G418. PubMed ID: 31905026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD.
    Wang J; Li P; Jiang Z; Yang Q; Mi Y; Liu Y; Shi R; Zhou Y; Wang J; Lu W; Li S; Liu D
    Korean J Intern Med; 2016 May; 31(3):479-87. PubMed ID: 27025268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of alcoholic and nonalcoholic fatty liver disease in China.
    Fan JG
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():11-7. PubMed ID: 23855290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality.
    Younossi Z; Henry L
    Gastroenterology; 2016 Jun; 150(8):1778-85. PubMed ID: 26980624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Causes of Mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol Related Fatty Liver Disease (AFLD).
    Johnston MP; Patel J; Byrne CD
    Curr Pharm Des; 2020; 26(10):1079-1092. PubMed ID: 32003662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic and Detrimental Effects of Alcohol Intake on Progression of Liver Steatosis.
    Di Ciaula A; Bonfrate L; Krawczyk M; Frühbeck G; Portincasa P
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphatase and tensin homolog is a differential diagnostic marker between nonalcoholic and alcoholic fatty liver disease.
    Sanchez-Pareja A; Clément S; Peyrou M; Spahr L; Negro F; Rubbia-Brandt L; Foti M
    World J Gastroenterol; 2016 Apr; 22(14):3735-45. PubMed ID: 27076758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiological similarities and synergisms in alcoholic and non-alcoholic steatohepatitis.
    Hellerbrand C
    Dig Dis; 2010; 28(6):783-91. PubMed ID: 21525763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty Liver Disease-Alcoholic and Non-Alcoholic: Similar but Different.
    Malnick SDH; Alin P; Somin M; Neuman MG
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis and pathways: nonalcoholic fatty liver disease & alcoholic liver disease.
    Robinson KE; Shah VH
    Transl Gastroenterol Hepatol; 2020; 5():49. PubMed ID: 33073044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics of alcoholic and nonalcoholic fatty liver disease.
    Anstee QM; Daly AK; Day CP
    Semin Liver Dis; 2011 May; 31(2):128-46. PubMed ID: 21538280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological features of fatty liver disease.
    Yeh MM; Brunt EM
    Gastroenterology; 2014 Oct; 147(4):754-64. PubMed ID: 25109884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of CCl
    Brol MJ; Rösch F; Schierwagen R; Magdaleno F; Uschner FE; Manekeller S; Queck A; Schwarzkopf K; Odenthal M; Drebber U; Thiele M; Lingohr P; Plamper A; Kristiansen G; Lotersztajn S; Krag A; Klein S; Rheinwalt KP; Trebicka J
    Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G182-G194. PubMed ID: 31188634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.